Introduction
The National Science Foundation has estimated that nanotechnology is to be worth $1 trillion by 2015 1 and that engineered nanomaterials represent a growing class of material being introduced into multiple business sectors. However, there are also concerns surrounding the potential harmful effects of engineered nanomaterial imposed on health and the environment. The immediate goal to regulate without hampering public perception on the benefits of nano-enabled products but scientific findings have not yet provided any clear answers on the toxicity of nanomaterials 2 . The real danger here is that regulation will run ahead of scientific reality, which may lead on the tightening or loosening of regulations, thus affecting either the nanomaterial manufacture sectors or the environment and human health.
The need to develop a sound infrastructure for assessment of risk is clear. However, the variety of nanomaterials is great. Subsequently, this will mean the need to test large number of nanomaterial/matrix combination; this makes it difficult to assess the possible hazard and risk of each nanomaterial. In the chemical world, an "intelligent testing" approach is employed in order to improve testing efficiency. One strategy to alleviate the problem is through the establishment of chemical categories, which relies on "similarity principle" i.e. similarities in the structure of different molecules/compounds that may create predictable patterns of particular biological activity/toxicity endpoints. This allows untested chemicals to be categorised by assuming that the biological activity is linked to their molecular structure, as determined by compositional and structural descriptors such as size, elemental composition, topology and functional groups 3 . Categorisation has meant the ability to streamline hazard and risk assessment process; where costs are concerned, this will mean that a particular chemical group can be assessed as a whole, without the need to test every category member for every regulatory endpoint. Moreover, in relation to ethical considerations, a great deal of animal experimentation will be reduced. This is particularly attractive in certain market categories, such as European cosmetic products (e.g. skin creams, oral care, shampoo, conditioner, deodorants, etc.) in which restrictions on in vivo testing exist.
The development of chemical categories often involves the need to estimate missing entries. This can be achieved through the use of trend analysis, which often involves a form of interpolation and extrapolation. Interpolation can be defined as the estimation of a value between two known data points 4, 5 . Extrapolation is an estimate of a value based on extending a known sequence of values near or at the category boundary using measured values from internal category members 5 . Another approach to estimate missing experimental values is to use read across, which involves using information on one chemical structure and making some assessment about the relevance of that information for a second chemical structure considered similar 5 . Hence, methods of extrapolation and read across are therefore inherently more risky than interpolation. In addition to trend analysis and read across, the use of in silico methods such as (Q)SAR, 6 is attractive to many industry and regulators. The predictive ability of in silico methods resulted in REACH to promote the use of (Q)SAR to develop chemical categories 7, 8 .
It is not the intent of this paper to delve into the details of the processes involved in (Q)SAR, as they have been covered in great details elsewhere and the reader is referred to the relevant past literature 7,9-11 . Only a brief summary will be given in order to familiarise the reader with the basics of this topic. (Q)SAR is a collective term that refers to both Structure-Activity Relationships (SAR) and Quantitative Structure-Activity Relationships (QSAR). Both are theoretical models, used to predict "analysed activity" (e.g. some biological endpoints) from "descriptor values". Whereas QSAR is a numerical measure i.e. mathematical (regression), SAR is more qualitative in nature i.e. categorisation. In relation to chemicals the descriptors are often referred to as molecular descriptors, which can range from geometrical and topological (e.g. moment of inertia, accessible surface area and volume, aspect ratios) to electronic (e.g. HOMO and LUMO energies, dipole moment); the descriptors here can either be measured (experimental) or calculated (theoretical numerical values). (Q)SAR model is created using a data set referred to as the training set e.g. chemicals for which activity is known. In QSAR, the model is constructed by using classical chemoinformatic methods, such as classical linear methods (e.g. partial least squares and multiple linear regression), and non-linear methods (e.g. support vector machine and artificial neural networks) [12] [13] [14] [15] [16] . Modellers also sometimes employ principal component analysis (PCA) to aid the process of designing (Q)SARs 17, 18 e.g. for searching for structural similarity patterns and thus predefining new categorises of the studied chemicals. In SAR, as there is no attempt to derive a quantitative model, artificial intelligence methods such as decision trees and discriminant analysis are used instead 19 . The most crucial steps in (Q)SAR are to demonstrate the robustness of the model (validation) and to set the boundaries of the validated model which define the domain of applicability. This helps to check which external chemicals can be predicted using the built model and to establish how the model will perform when faced with compounds that were not included in the training or test set.
The use of (Q)SARs in order to categorise chemicals is quite advanced, which in turn have allowed past workers to create a broad hazard identification profile, prioritise chemicals and estimate values for untested chemicals [20] [21] [22] [23] [24] [25] [26] [27] [28] . Furthermore, the development of chemical categories have also been used to identify hazards (associated with safe storage, handling and disposal of waste) [29] [30] [31] [32] , prediction of physicochemical properties or toxic/biochemical effects [33] [34] [35] [36] and provide information about mechanism of action 37, 38 , thus promoting the safe use of chemicals.
Unlike chemicals, no clear strategy is in place to categorise nanomaterials. Several suggestions have been made. Glotzer and Solomon 39 suggests that nanomaterials can be categorised through the use of eight orthogonal dimensions (surface coverage, aspect ratio, faceting, pattern quantization, branching, chemical ordering, shape gradient, and roughness) in order to describe the key attributes of nanomaterials. Hansen and Stone suggested the use of a chemistry based categorisation system as a starting point 40, 41 . Although little work has been done in relation to the use of (Q)SAR to categorise nanomaterial, the approach (of using such models much in the same way as in chemicals) would be attractive, if proven possible.
In 2009, Puzyn coined the term nano(Q)SAR i.e. (Q)SAR models that correlate the physicochemical properties of nanomaterials to their biological activity 42 . To date, several alternative acronyms on top of nano-(Q)SAR have been used to describe the same method, which includes: Quantitative Nanostructure-Activity Relationships (QNAR) 43 and Quantitative Nanostructure-Toxicity Relationships (QNTR) 44 . For the remainder of the manuscript the term of nano(Q)SAR shall be used throughout. Unlike the use of (Q)SAR in chemicals, nano-(Q)SAR is still at an early stage 45 , far from successful uptake in relation to nano-regulation.
The purpose of the paper is to understand the pitfalls and challenges associated with nano(Q)SAR and research requirements in order to develop reliable nanomaterial categories. In order to meet this objective, we will be reviewing past literature on nano-(Q)SAR and report relevant findings to their use for categorisation of nanomaterials. We will present criteria necessary in the use of (Q)SAR to categorise chemicals and translate this to nano(Q)SAR. Finally, we will identify the pitfalls/barriers associated and discuss future work necessary for implementation.
Much of the source material presented for this paper is from peer-reviewed papers as well as grey literature e.g. guidelines/scientific opinion documents for regulations, with relevance to the objectives stated.
Results and Discussion

Nano(Q)SARs: recent advances
To date, only a handful of studies on nano(Q)SAR have been carried out, with most studies reporting metal oxide nanoparticles due to their relatively high volume of use/production. . Different modellers have attempted to establish a link between different physicochemical descriptors and observed biological activity. Table 1 summarises some of the different predictors used by different researchers. A total of twelve descriptors have been associated with nano(Q)SAR; these are the physicochemical properties of potential relevance to toxicity, although no clear and valid mechanistic understanding has been developed. There are some common descriptors i.e. have been reported by more than once. These are: particle size, zeta-potential, surface modifications and spin-spin relaxivities. Out of all of these, surface modification is the most common, indicating the importance of this property and its relevance to toxicity. From the table, it is clear that apart from Liu and co-workers (who have developed nanoSAR) 49, 53, 54 , most of the studies have been associated with nanoQSAR. In general, much work is still needed in the field, in particular the application of nano(Q)SAR to the development of nanomaterial categories. The first step is to identify the criteria imposed for uptake, which will be similar to those identified for corresponding chemicals. According to an OECD guideline 7 on (Q)SAR, the basic criteria that must be fulfilled is the generation of reliable and validated models, which will allow confidence in the predictions made. However, barriers exists, which prevent the criteria from being fulfilled and these will be further assessed below. Once these basic criteria are fulfilled, then there is a need to have a clear implementation route i.e. towards industry uptake and regulatory acceptance.
Barrier 1: the generation of a reliable model
Unlike chemicals, measuring the physicochemical characteristics of nanomaterials is not straightforward with current instrumentations. From a scientific perspective, nanomaterials cannot be considered as a homogeneous group and subsequently this means that getting reliable data is not easy to achieve. Potentially, this leads to a situation in which experimental data gets reported without proper understanding of the associated errors and the propagation of these errors through the model. Sources of errors may arise from a number of factors including polydispersity, biological environment and inappropriate measurement.
In relation to the polydispersity of nanomaterial, it has been argued by Baalousha and Lead 55 that most nanomaterials tested are too polydisperse. Materials close to monodispersity are needed in order to have better reliability of result findings associated with studying environmental behaviour, dose, structure-activity relationships and mechanisms of toxicity. Although there is great effort in the scientific community to develop test/reference materials e.g. OECD Working Party on Manufactured Nanomaterials 56 ), there is a need to address whether the commercially relevant nanomaterials offered held in this repository are suitable for the purpose nano(Q)SAR models. If monodisperse and homogeneous nanomaterial sample is needed, then only a handful of nanomaterials in existence have been certified and sold under the banner of reference nanomaterials, to include National Institute of Standards and Technology (NIST) gold nanoparticle reference materials (10, 30 and 60 nm). The use of such materials are ideal for use in nanotoxicology studies and recently they been shown suitable to act as negative controls for nanoparticle genotoxicity studies 57 .
With respect to the analytical techniques currently available, it is difficult to measure accurately, a highly polydisperse sample. In a recent study, Anderson et al. 58 show that complex particle size distributions i.e. away from the simple monomodal distribution will result in large data variability. It was reported that light scattering based Particle Tracking Analysis and Dynamic Light Scattering platforms were only able to detect a single population of particles corresponding either the largest or smallest particles in a multimodal sample. Clearly, the inadequacy of the instrumental methods to characterise nanomaterials is a huge barrier in this field, as echoed by several past workers 2, 55 .
In addition to polydispersity issue, the complex biological matrix in which the particles are dispersed in can also pose problems where measurement is concerned, potentially resulting in agglomeration and thus the formation an unstable suspension. Furthermore, nanomaterial-media interactions can be dynamic in nature, which may pose further difficulties for the instrument to measure under such conditions. Finally, physicochemical properties measured may not being directly associated with the observed biological effects. Due to the analytical challenges posed in a) and b), some studies have characterised nanomaterials in their "pristine" state i.e. absence of the actual biological test media. In fact, few studies have assessed the potential transformation of nanomaterials in an environmental or mammalian system 59, 60 .
In addition to measurement of physicochemical properties, measurements of biological endpoints may also be problematic. In in vitro measurements, there are several biological endpoints that reflect changes associated with cell activity, which may be employed to indicate toxicity hazard related to the nanomaterial under investigation. Examples include: evidence of appreciable cell death relative to suitable control experiments, growth retardation and cell membrane damage. There are several bioassay tests that can measure these biological endpoints but the results may not be reliable. The following potential sources of errors, which may lead to false interpretation, have been previously identified as being problematic: a) endotoxin (LPS, lipopolysaccharide) contamination in the nanomaterial 61 .
b) choice of inappropriate end-points for the nanomaterial. There is a need to define a standard set of biological assays (and protocols) clearly in order to evaluate the overall in vitro (and in vivo) response of the tested nanoparticles. The assay chosen should be truly indicative of key activity, property or toxicological effects caused by these nanomaterials 62 .
c) interference in the assay readout by the nanomaterials e.g. tetrazolium based assays and the subsequent potential interference of the nanomaterials with the formazan salts 63,64 .
d) varied nanomaterial dispersion protocols, including differences in the amount, source and pre-treatment of serum proteins used (affecting particle size distribution and agglomerates/aggregates population, etc.) 65, 66 .
The problems identified so far imply the need to develop better research techniques/ methods and that the developed methods are validated. Eurachem 67 clearly states that analytical measurements should be made using methods and equipment which have been tested to ensure that they are fit for purpose. The current state of toxicological research in nanomaterials is that methods developed are rarely validated.
Once the conditions of the method validation are met, only then can researchers consider a higher metrological standard of measurement, conduct uncertainty analyses to estimate uncertainty and the propagation of uncertainty. The need to have reliable data for the nano-(Q)SAR model may mean that for the first step of developing a robust nano-(Q)SAR model, it would be easier (more achievable) to build a model for engineered nanomaterials using homogeneous, monodisperse samples in environments where agglomeration of the nanomaterials would be relatively low.
Another factor that influences the reliability of the nano(Q)SAR model is in the selection of descriptors. Having an agreement on suitable descriptors is important, as past workers found that the choice of descriptors can affect the quality, significance and interpretation of nano-(Q)SAR model 10, 52 . It may be that descriptors can be selected or adapted from traditional chemical descriptors, but it is highly likely that descriptors specifically developed for nanomaterials are needed. For example, Borders et al have shown that new types of defects in carbon nanotubes can be represented as a new descriptor in the prediction of its mechanical properties 68 . In a recent study, Wang et al. 69 have shown how Principal Component Analysis (PCA) can be used in order to identify potentially suitable descriptors. Through the use of PCA, they identified: particle charge, aspect ratio and metal content as potential descriptors. In summary, much attention must be given to the selection of trial descriptor sets when developing nano(Q)SAR models, as they play a pivotal role in predictive quality of the model.
Barrier 2: validation of the model
A pre-requisite for the uptake of (Q)SAR 7 and subsequently nano(Q)SAR, is for the model to be validated. It states clearly that the principles for validation should include: a defined endpoint, an unambiguous algorithm, a defined domain of applicability, appropriate measures of goodness-of-fit, robustness, predictivity and a mechanistic interpretation, if possible. Validation is vital to ensure that the predictive ability of the model is not due to chance factors.
Validation for nano(Q)SAR is not straightforward due to the following reasons:
a) The heterogeneity of nanomaterial family: There is a need to develop separate models that are specific to nanomaterial types and thus properties 70 . Due to large number of nanomaterial types that can be engineered (and subsequently different mechanisms of toxicity), it has been suggested by Puzyn that individual classes of nanomaterials should be modelled separately 42 .
b) The paucity of data available for nano(Q)SAR: Since nano(Q)SARs are developed with statistical methods (MLR, neural networks etc.), the variance in the group of nanomaterial needs to be sufficiently represented in the training and validation sets of particles. It is commonly accepted that the ratio between the number of descriptors and compounds in the training set should be at least as 1 to 5 71, 72 .
c) The lack of standardized validation metrics: The approach used for validation needs to be defined, for example whether to employ variants of cross validation or external test set validation 73 . Ideally, validation should be done externally i.e. by an external predication set, in which the test data set has to be independent not only from model building but also from model selection 74 . However, this step may not be always possible. If additional testing is not feasible then an internal validation may be carried out e.g. using the "leave one out" cross validation (CV) method; CV is carried out by omitting a point and then calculating the value of this location using the remaining points 75 . Having said this, Tropsha et al. 76 demonstrated that leave-one-out cross validation and external test set metrics do not correlate 77 and stated that a "high value of leave-one-out cross-validated R 2 appears to be a necessary but not sufficient condition for a model to have a high predictive power". It should also be noted that the model's predictivity can only be confirmed with external validation without which the (Q)SAR modelling procedure is incomplete.
Barrier 3: improving industry uptake and regulatory acceptance
In relation to chemicals, there seems to be a clear regulatory application of (Q)SAR in the US but this is less so in Europe 78 . The wider acceptance of (Q)SAR in the US is attributed to the need to evaluate chemical substances within a relatively short period of time. The US Environmental Protection Agency (EPA) in particular is keen to promote the use of (Q)SAR to develop chemical category in hazard and risk assessment 79 . In the European Union, regulatory acceptance of (Q)SARs is limited. There is a push by REACH, through activities arising from the existing OECD chemicals programme 7, 80 , to promote the use of (Q)SAR as an alternative method to evaluate chemicals. Clearly, the fact that implementation of (Q)SAR in Europe is still problematic for chemicals, means that nano(Q)SARS will not easily be accepted in the near future. In order to implement nano(Q)SAR it is vital to demonstrate to regulators, and industry, that nano(Q)SARs are scientifically validated and clear explanations on how to use such models for making decisions 45 should also be given. Once this is achieved, we can then "harmonise activities" e.g. by forging internationally agreed document standards and guidelines. Guidelines of relevance should include the provision of detailed guidance in relation to the practicalities on the use of nano-(Q)SAR e.g. detailing how to identify acceptability criteria, how to generate adequate and relevant descriptors [81] [82] [83] .
Conclusion
There is a widespread regulatory and scientific interest in developing intelligent and cost effective testing. In particular REACH is promoting the use of alternative methods such as (Q)SAR for the purpose of categorising chemicals. One of the most important characteristics of (Q)SAR is in their predictive power, having been seen as "an enabler" in bringing new chemicals to commercialisation.
The recent application of (Q)SAR to nanomaterials shows that researchers are starting to use such models in order to categorise nanomaterials in the same way as chemicals. This may be beneficial as it aims to improve the efficiency of hazard and risk assessment. This may be is useful in market categories where there is a restriction on in vivo testing. However, it is clear from this review that the valid implementation of nano-(Q)SAR is a long way off, as past experience associated even with chemicals shows the considerable amount of time and effort needed to implement the use of such tools at an internationally acceptable level.
Several issues have been highlighted in this review, which cast serious doubts over the reliability of such models to support nano-regulation. If nano-(Q)SAR is to be implemented, then issues associated with experimental data quality used to develop the model in the first place must be tackled. We have identified the need for better analytical techniques to deal with polydispersity in a sample and when the nanomaterial is dispersed in complex media. In addition, there is a need to have validated methods and more ideal test/reference materials. These activities are valuable for any understanding of nanomaterials not just for nano(Q)SARS. In relation to the development of the model itself, there is a need to generate practical guidance e.g. identification of relevant descriptors for nanomaterials. Once the issues associated with reliability have been tackled, the next step is to ensure better co-ordination between the scientific community with industry and regulatory authorities.
Overall, the first step is to generate reliable nano(Q)SAR models and that as part of the validation process, an external validation with independent series of data should be used. If this can be achieved, internationally agreed documentary standards and guidelines can be generated.
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